A - Rasio utang marang kapitalisasi buku Agilent Technologies, Inc.

Logo korporat perusahaan Agilent Tech (A)

Agilent Technologies scales profits through IT services and a broad portfolio of instruments. High barriers to entry are ensured by unique patents and stringent government regulation. However, geopolitical fragmentation complicates equipment exports to Asia. The dynamic debt-to-book capitalization ratio visualizes financial stability, with the metric value standing at 0.55, allowing for an assessment of the business's reliance on borrowed funds.

Agilent Technologies (A) - Utang-utang marang nilai buku saka 04.07.2022 nganti 27.10.2026
Produk merek Agilent Tech

High volatility in the debt-to-equity ratio signals that Agilent Technologies (A) is vulnerable to cash flow gaps during sharp price declines. However, the technological barrier and high switching costs for customers create a foundation of resilience, which, through the total debt-to-balance sheet capital chart, allows investors to assess the actual level of leverage and the risks of financial destabilization.

Pesaing Agilent Technologies

Utang-utang marang kapitalisasi buku DGX (Quest Diagnostics)|illumina.com - Utang-utang marang kapitalisasi buku|EXAS - Rasio utang marang kapitalisasi buku|Revvity Inc (RVTY) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku BIO|NNNN (Anbio Corp) - Utang-utang marang nilai buku|SHC: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik quidel.com|OPK (OPKO Health) - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik CDNA (CareDx, Inc)|Rasio utang marang kapitalisasi buku MRVI|Utang-utang marang aset resik Fulgent FLGT|Standard BioTools Inc. - Utang-utang marang kapitalisasi buku|CTKB - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku OSUR (OraSure)|Exagen (XGN) - Utang marang aset resik|MDXH: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik LUCD|Rasio utang marang kapitalisasi buku Prenetics Global (PRE)|Rasio utang marang kapitalisasi buku imdxinc.com (IMDX)|TRIB: Utang-utang marang kapitalisasi buku|ProPhase Labs Inc - Utang-utang marang nilai buku|Ainos Corp (AIMD) - Rasio utang marang kapitalisasi buku|CoDx (CODX) - Rasio utang marang nilai buku|HSCS - Utang marang nilai buku|Utang marang modal buku biomerica.com|CDIO - Utang marang nilai buku|Rasio utang marang aset resik Virax Biolabs Group Limited (VRAX)|Utang marang nilai buku Bluejay|Utang marang modal buku Aspira Women's Health Inc (AWH)|AXDX: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku centogene.com CNTG|ENZ: Utang-utang marang kapitalisasi buku|FRES - Utang marang nilai buku|Utang-utang marang kapitalisasi buku gtglabs.com GENE|ME (23andMe Inc) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku Psychemedics (PMD)